| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.0M | +19.1% |
| R&D Expense | $2.2M | -35.9% |
| SG&A Expense | $11.5M | +2.3% |
| Operating Income | $11.6M | -20.9% |
| Interest Expense | $1.1M | -40.5% |
| Pre-tax Income | $18.4M | +25.7% |
| Income Tax | $4.9M | +483.4% |
| Net Income | $13.5M | -15.1% |
| EPS (Basic) | $1.09 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.9M | +31.6% |
| Current Assets | $20.3M | +70.6% |
| Total Assets | $332.2M | -0.6% |
| Current Liabilities | $5.6M | +41.1% |
| Long-term Debt | $33.0M | +0.0% |
| Total Liabilities | $43.5M | -19.3% |
| Stockholders' Equity | $288.7M | +3.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $23.0M | +54.8% |
| Capital Expenditures | $138K | -72.2% |
| Investing Cash Flow | -$10.1M | +79.3% |
| Financing Cash Flow | -$12.2M | -136.9% |
| Free Cash Flow | $22.9M | +59.2% |
| -13.5% |
| EPS (Diluted) | $1.08 | -13.6% |